Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Nephrotic Syndrome Market Growth in 2025?
In recent times, the market size of nephrotic syndrome has expanded at an impressive pace. The market, which stood at $0.87 billion in 2024, is projected to increase to $00.96 billion by 2025, clocking a compound annual growth rate (CAGR) of 11.0%. This expansion during the historical period can be traced back to factors such as a rise in the cases of nephrotic syndrome, an upsurge in genetic disorders, escalating obesity rates, an increased employment of immunosuppressive medications, as well as an amplified influence of genetic elements.
What Is the Forecast for the Nephrotic Syndrome Market Size Through 2029?
The market for nephrotic syndrome is projected to witness swift expansion in the upcoming years and is anticipated to reach a value of $1.44 billion by the year 2029, demonstrating a compound annual growth rate (CAGR) of 10.7%. Several factors including increasing awareness about Nephrotic Syndrome, growing instances of Chronic Kidney Disease (CKD), escalating incidence of metabolic ailments, expanding elderly population, and surging prevalence of autoimmune diseases could drive this growth during the forecast period. Important trends that may emerge during this period encompass telemedicine and remote health monitoring, pioneering drug delivery methods, innovation in therapeutic practices, advancements in the field of biotechnology, and the incorporation of digital health technologies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21228&type=smp
What are the Key Market Players in Nephrotic Syndrome Market and How They’re Evolving?
Major companies operating in the nephrotic syndrome market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Eli Lilly and Company, Asahi Kasei Corporation, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals, Chugai Pharmaceutical Co. Ltd., Mallinckrodt Company, Evotec SE, Travere Therapeutics Inc., Aurinia Pharmaceuticals Inc., Orbis Biosciences Inc., Alpine Immune Sciences, Kezar Life Sciences, Zenyaku Kogyo Co. Ltd
What Are the Primary Growth Drivers in the Nephrotic Syndrome Market?
The escalation in kidney diseases is anticipated to drive the growth of the nephrotic syndrome market. Kidney diseases encompass any disorder or condition that impairs the kidney’s ability to function and filter out waste and excess fluids from the bloodstream. The rising prevalence of kidney diseases can be attributed to factors like diabetes, high blood pressure, obesity, aging demographic, and changes in lifestyle habits, including high sodium consumption and insufficient hydration. Nephrotic syndrome worsens kidney diseases by damaging the glomeruli, leading to the kidneys’ inability to filter waste and retain vital proteins. For example, data from the Australian Institute of Health and Welfare, a government agency based in Australia, showed in June 2024, that the rate of chronic kidney disease (CKD) mortality in Australia escalated from 4.2% in 2021 to 6.2% in 2022. Hence, this escalating prevalence of kidney diseases is fueling the growth of the nephrotic syndrome market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21228&type=smp
What Are the Leading Segments in the Global Nephrotic Syndrome Industry?
The nephrotic syndrome market covered in this report is segmented –
1) By Type: Drugs, Devices
2) By Diagnosis Tests: Urinalysis, Glomerular Filtration Rate (GFR), Blood Test, Kidney Biopsy, Computerized Tomography (CT) Scan
3) By Application: Clinics, Hospitals, Speciality Centres, Other Applications
Subsegments:
1) By Drugs: Steroids, Immunosuppressants, Diuretics, ACE Inhibitors Or ARBs, Other Drugs
2) By Devices: Dialysis Machines, Peritoneal Dialysis Catheters, Hemodialysis Catheters, Kidney Replacement Therapy Devices
What Are the Key Market Trends in the Nephrotic Syndrome Industry?
The nephrotic syndrome market’s main players are collaborating to create advanced formulas like loop diuretic injections. These injections aim to enhance fluid control and minimize swelling in patients with nephrotic syndrome. The term “Loop diuretic Injection” describes a drug that prevents the absorption of sodium and chloride in the Henle’s loop, which results in increased urine production. It’s primarily used to address acute pulmonary edema, heart failure, and severe hypertension by lowering fluid overload. For instance, in March 2024, Avenacy Inc., a pharmaceutical company from the U.S. introduced a generic version of Lasix called furosemide for Injection, which was FDA-approved, intended for edema treatment related to heart failures, liver cirrhosis, and kidney diseases. The drug, offered in 25-unit packs each containing 100 mg/10 mL doses, is part of wider expansion plans by Avenacy to broaden its injectable medicine portfolio with over 20 product launches planned in 2024. It is indicated for adults and pediatric patients to treat edema associated with congestive heart failure, liver cirrhosis, and kidney diseases, such as nephrotic syndrome.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/nephrotic-syndrome-global-market-report
What Is the Regional Outlook for the Nephrotic Syndrome Market?
North America was the largest region in the nephrotic syndrome market in 2024. The regions covered in the nephrotic syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21228
This Report Delivers Insight On:
1. How big is the nephrotic syndrome market, and how is it changing globally?
2. Who are the major companies in the nephrotic syndrome market, and how are they performing?
3. What are the key opportunities and risks in the nephrotic syndrome market right now?
4. Which products or customer segments are growing the most in the nephrotic syndrome market?
5. What factors are helping or slowing down the growth of the nephrotic syndrome market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model